2.52

1.94% -0.06

Alaunos Therapeutics Inc (TCRT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Alaunos Therapeutics Inc stock is traded at $2.52, with a volume of 4,757. It is down -1.94% in the last 24 hours and up +3.27% over the past month. Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Previous Close:

$2.58

Open:

$2.57

24h Volume:

4,757

Relative Volume:

0.01

Market Cap:

$4.02M

Revenue:

Net Income/Loss:

$-36.46M

P/E Ratio:

-1.05

EPS:

-2.4

Net Cash Flow:

$-30.20M

1W Performance:

-4.89%

1M Performance:

+3.27%

6M Performance:

-1.94%

1Y Performance:

-75.90%

1-Day Range:

$2.45

$2.6932

1-Week Range:

$2.45

$2.6932

52-Week Range:

$1.3137

$11.50

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name

Alaunos Therapeutics Inc

Sector

Healthcare (1177)

Industry

Biotechnology (671)

Phone

(346) 355-4099

Address

2617 BISSONNET ST, HOUSTON

Employee

Twitter

Next Earnings Date

2024-12-12

Latest SEC Filings

TCRT's Discussions on Twitter

Compare TCRT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TCRT Alaunos Therapeutics Inc	2.454	4.33M	0	-36.46M	-30.20M	-2.40
ONC Beone Medicines Ltd Adr	246.59	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	443.68	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.32	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	80.89	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	493.00	64.44B	14.09B	4.50B	2.96B	39.28

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-04-22	Resumed	Wells Fargo	Overweight

Alaunos Therapeutics Inc Stock (TCRT) Latest News

May 27, 2025

Alaunos Therapeutics Secures $25M Equity Purchase Deal - MSN

May 27, 2025

May 16, 2025

Ziopharm: Q1 Earnings Snapshot - CT Insider

May 16, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 2.4% – Time to Sell? - Defense World

May 16, 2025

May 14, 2025

PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics - TipRanks

May 14, 2025

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire

May 14, 2025

PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan

May 14, 2025

Apr 24, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Up 2.5% – Time to Buy? - Defense World

Apr 24, 2025

Apr 18, 2025

Alaunos Therapeutics announces board member resignation - Investing.com Australia

Apr 18, 2025

Alaunos Therapeutics announces board member resignation By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 16, 2025

Form 8-KCurrent report - ADVFN

Apr 16, 2025

Apr 15, 2025

Alaunos Therapeutics Board Opts for Equity Compensation - TipRanks

Apr 15, 2025

Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock By Investing.com - Investing.com Canada

Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock - Investing.com

Apr 14, 2025

Apr 04, 2025

Alaunos Therapeutics And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 04, 2025

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Down 12.5% in March - Defense World

Apr 04, 2025

Apr 03, 2025

11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 03, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday SessionAllakos (NASDAQ:ALLK), Alumis (NASDAQ:ALMS) - Benzinga

Apr 02, 2025

Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025

Mar 31, 2025